Value-based agreements could disrupt how we pay for drugs - STAT

Value-based agreements could disrupt how we pay for drugs - STAT

Value-based agreements could disrupt how we pay for new therapies

By STEVE BROZAK

WIN MCNAMEE/GETTY IMAGES

Paying for therapies based on the value they provide could revolutionize how medicines are priced and reimbursed in the U.S.

READ MORE